SOUN 10-Q report for 2026-03-31
This play records that SoundHound AI, Inc. (SOUN) filed a Form 10‑Q for the quarter ended March 31, 2026. The submitted excerpt is the filing cover/header only and contains issuer and security identifiers (SOUN, SOUNW) but no financial results, risk updates, liquidity detail, or management discussion to support a directional investment view.
Linked assets
Linked tickers: SOUN (common stock) and SOUNW (warrants). The cover page confirms security identifiers but provides no financials or warrant valuation context.
Common stock of SoundHound AI, Inc.; filing cover page confirms ticker and listing but includes no operational or financial disclosures.
Need the full 10‑Q (income statement/cash flow, liquidity, guidance, risk factor changes) to build a directional thesis.
Warrants (SOUNW) referenced on the filing cover; exercise terms and valuation context are not present in the excerpt.
Warrants require underlying fundamentals and warrant terms/valuation context; not available in excerpt.
Source proof
Source is the cover/header page of SoundHound AI, Inc.’s Form 10‑Q for the period ended 2026-03-31. The excerpt includes filing metadata (registrant name, CIK, exchange listing, and securities outstanding) but does not include income statement, balance sheet, cash flow statement, MD&A, note disclosures, risk-factor updates, or management guidance.
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
The provided text is only the cover/header portion of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.
This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.
This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.
This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.
The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.
Supporting authors
Prepared from the provided 10‑Q cover-page excerpt. No additional source material or authors contributed.
Unlock full thesis monitoring
Recommendation: Hold. Obtain and review the full Form 10‑Q (complete financial statements, liquidity/cash-flow detail, MD&A, and notes) before updating any buy/sell conviction. Monitor for subsequent SEC filings or company disclosures that include material operating or financial information.